This content was submitted directly to this Web site by the supplier.
Download the latest edition of HCP’s Serialization Playbook that will bring you up to date on DQSA/DSCSA, and what it means for your serialization efforts. Learn More »
The committee is charged with identifying companies that provide synergies and logical product extensions in the industries Medbox serves.
Utilizing its strong stock price, which has recently settled into the $20 range and boasting a market capitalization of over $245 million, the company is actively pursuing select strategic acquisitions of 50% or more ownership of entities in the following market segments:
Pharmaceutical packaging (prescription bags and vials)
Security and control (ability to implant RFID technology into packaging for unit tracking and security)
Mag-stripe card manufacturers
Medical cannabis lab testing
Cannabinoid research and development companies
"With the interest in Medbox being shown by alternative medicine dispensaries, assisted living facilities, hospice, urgent care centers, and prisons, expanding our capability to offer a full range of solutions, covering all touch points, will best serve our clients' interests, and open more market opportunities for the company," stated Dr. Bruce Bedrick, CEO of Medbox, Inc. "We are encouraged by the fact that our user base is growing at an enormous rate. Being able to profit from products and services offered to those clients makes a lot of sense for the company as well as our shareholders."
To avoid dilution to shareholders, the company's executives, founders, and affiliates, who possess over 90% of the company's stock will becontributing up to 2,000,000 shares of Medbox stock, valued at approximately $45,000,000, back to the company to support acquisition activity.
Principals and financial intermediaries are welcome to contact the company in confidence at [email protected]. Companies must submit 3 years of complete financials for consideration.